| scholarly article | Q13442814 |
| P50 | author | Harald Hampel | Q38328382 |
| Frank Faltraco | Q57433022 | ||
| P2093 | author name string | David Prvulovic | |
| Simone Lista | |||
| P921 | main subject | biomarker | Q864574 |
| Alzheimer's disease | Q11081 | ||
| P304 | page(s) | 1-17 | |
| P577 | publication date | 2012-06-26 | |
| P1433 | published in | Progress in Neurobiology | Q15716615 |
| P1476 | title | Blood and plasma-based proteomic biomarker research in Alzheimer's disease | |
| P478 | volume | 101-102 |
| Q92898086 | A Clinician's Perspective on Biomarkers |
| Q51760901 | A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication. |
| Q47098359 | A validated antibody panel for the characterization of tau post-translational modifications |
| Q46723406 | Analysis of human blood plasma and hen egg white by chiroptical spectroscopic methods (ECD, VCD, ROA). |
| Q58586056 | Application of Bézier Curves for Calculating Likelihood Ratios for Plasma Amyloid-β Biomarkers for Alzheimer's Disease |
| Q27024518 | Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics |
| Q36926754 | Blood protein predictors of brain amyloid for enrichment in clinical trials? |
| Q26774743 | Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology |
| Q57295586 | Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic |
| Q49135523 | Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic |
| Q64108130 | Blood-based molecular biomarkers for Alzheimer's disease |
| Q26830098 | Body fluid biomarkers in Alzheimer's disease |
| Q47587631 | Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry |
| Q92856700 | Cofilin 2 in Serum as a Novel Biomarker for Alzheimer's Disease in Han Chinese |
| Q24289443 | Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges |
| Q60310921 | Current state of Alzheimer's fluid biomarkers |
| Q90149235 | Dielectric Constant and Conductivity of Blood Plasma: Possible Novel Biomarkers for Alzheimer's Disease |
| Q53481618 | Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease. |
| Q93178292 | Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay |
| Q47934049 | Effective litmus gene test for monitoring the quality of blood samples: Application to Alzheimer's disease diagnostics |
| Q47139195 | Electrochemical Detection of Plasma Immunoglobulin as a Biomarker for Alzheimer's Disease. |
| Q30996727 | Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline |
| Q50999408 | Evolving Relevance of Neuroproteomics in Alzheimer's Disease. |
| Q24289435 | Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research |
| Q91868125 | IGFBP-2 Signaling in the Brain: From Brain Development to Higher Order Brain Functions |
| Q92387684 | Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective |
| Q92069930 | Isoelectric point region pI≈7.4 as a treasure island of abnormal proteoforms in blood |
| Q55279842 | Lavandula angustifolia Effects on Rat Models of Alzheimer's Disease Through the Investigation of Serum Metabolic Features Using NMR Metabolomics. |
| Q59791740 | Loss of Ca/Calmodulin Dependent Protein Kinase Kinase 2 Leads to Aberrant Transferrin Phosphorylation and Trafficking: A Potential Biomarker for Alzheimer's Disease |
| Q92192968 | Mass Spectrometry for the Study of Autism and Neurodevelopmental Disorders |
| Q34470350 | Mass spectrometry as a tool for studying autism spectrum disorder |
| Q38222163 | Mass spectrometry for the study of autism and neurodevelopmental disorders |
| Q62516674 | Metabolomics in Alzheimer's disease research |
| Q38569255 | Neuroproteomic profiling of human body fluids |
| Q46631793 | No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease |
| Q38344088 | Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies |
| Q38657429 | Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks |
| Q47417067 | Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults |
| Q39084782 | Plasma levels of apolipoprotein E and risk of dementia in the general population |
| Q35813149 | Plasma protein biomarkers of Alzheimer's disease endophenotypes in asymptomatic older twins: early cognitive decline and regional brain volumes |
| Q36256076 | Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease |
| Q37504001 | Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics |
| Q34500658 | Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? |
| Q38125769 | Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes. |
| Q51760905 | Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology. |
| Q47822179 | Serum Protein-Based Profiles as Novel Biomarkers for the Diagnosis of Alzheimer's Disease. |
| Q36165011 | The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations |
Search more.